IMBRUVICA 140MG CAPSULE (120 CAPSULES)

About IMBRUVICA 140MG CAPSULE (120 CAPSULES)

Imbruvica 140MG Capsule (120 Capsules) contains ibrutinib 140mg. It blocks Bruton's tyrosine kinase, which cancerous B-cells need to survive, which is why it is classed as a BTK inhibitor (targeted therapy). Specialists use it for chronic lymphocytic leukaemia, mantle cell lymphoma, Waldenstrom macroglobulinaemia and chronic graft-versus-host disease. During treatment expect regular checks such as heart rhythm, blood pressure and bleeding. Made by Johnson & Johnson; pack size 120 capsules. MRP Rs 391,081.20 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.

Uses of IMBRUVICA 140MG CAPSULE (120 CAPSULES)

• Treating certain types of blood cancers like chronic lymphocytic leukemia and mantle cell lymphoma
• Managing specific blood-related malignancies

Side effects of IMBRUVICA 140MG CAPSULE (120 CAPSULES)

• Diarrhea or nausea
• Fatigue
• Low blood cell counts leading to increased infection risk
• Bruising or bleeding easily
• Muscle and joint pain

Precautions for IMBRUVICA 140MG CAPSULE (120 CAPSULES)

• Avoid pregnancy and breastfeeding during treatment, as it can harm the baby.
• Inform your doctor about any history of bleeding disorders or liver problems.
• Avoid grapefruit and its juice as it may interact with the medicine.
• Tell your doctor about all other medicines, supplements, or blood thinners you are taking.